1. Home
  2. FLXS vs DRUG Comparison

FLXS vs DRUG Comparison

Compare FLXS & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexsteel Industries Inc.

FLXS

Flexsteel Industries Inc.

HOLD

Current Price

$44.84

Market Cap

245.0M

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$72.84

Market Cap

707.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLXS
DRUG
Founded
2001
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.0M
707.1M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
FLXS
DRUG
Price
$44.84
$72.84
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$124.00
AVG Volume (30 Days)
24.3K
104.6K
Earning Date
04-20-2026
05-14-2026
Dividend Yield
1.79%
N/A
EPS Growth
85.86
N/A
EPS
2.49
N/A
Revenue
$441,073,000.00
N/A
Revenue This Year
$5.10
N/A
Revenue Next Year
$3.56
N/A
P/E Ratio
$17.99
N/A
Revenue Growth
6.86
N/A
52 Week Low
$29.38
$23.18
52 Week High
$59.95
$123.75

Technical Indicators

Market Signals
Indicator
FLXS
DRUG
Relative Strength Index (RSI) 45.70 47.88
Support Level $43.54 $71.04
Resistance Level $47.99 $84.29
Average True Range (ATR) 1.74 4.11
MACD -0.01 0.07
Stochastic Oscillator 61.31 71.51

Price Performance

Historical Comparison
FLXS
DRUG

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: